STOCK TITAN

Medical Care Technologies Inc. (OTC PINK:MDCE) Launches AI Wound Monitoring Tool for $20+ Billion Chronic Care Market

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags
AI

Medical Care Technologies (OTC PINK:MDCE) has unveiled its innovative AI-powered Wound Monitoring System, leveraging smartphone imagery for real-time wound care diagnostics. The system utilizes sequential imaging algorithms, automated edge detection, and infection risk modeling to monitor healing progress and detect complications early.

The technology targets the $20+ billion chronic wound care market, which is expected to exceed $30 billion by 2030. The AI system will be integrated into MDCE's beta app launch in 2026 as part of its digital health ecosystem, aiming to reduce hospital readmissions and healthcare costs while improving patient outcomes.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • Targeting massive $20+ billion chronic wound care market with projected growth to $30 billion by 2030
  • Innovative AI technology could reduce healthcare costs and hospital readmissions
  • Technology provides cost-effective alternative to expensive in-person wound assessments
  • Integration planned into broader digital health ecosystem with 2026 beta app launch

Negative

  • Beta app launch not until 2026, indicating significant time to market
  • Product still in development phase with no current revenue generation
  • Faces regulatory and market adoption uncertainties as noted in forward-looking statements

News Market Reaction – MDCE

+33.33%
1 alert
+33.33% News Effect

On the day this news was published, MDCE gained 33.33%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MESA, ARIZONA / ACCESS Newswire / September 3, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced its AI-powered Wound Monitoring System, designed to provide real-time wound care diagnostics using only smartphone imagery.

The platform applies sequential imaging algorithms, automated edge detection, and infection risk modeling to track wound healing trajectories and flag early signs of infection or stagnation. This capability offers a disruptive alternative to expensive, in-person wound assessments-empowering patients, caregivers, and clinicians alike.

The chronic wound care market exceeds $20 billion annually and is projected to surpass $30 billion by 2030, driven by rising rates of diabetes, obesity, and aging populations. By addressing this global need, MDCE's system has the potential to reduce hospital readmissions, cut costs, and improve patient outcomes at scale.

"This technology has the potential to save billions in preventable healthcare costs while improving patient quality of life," said CEO Marshall Perkins.

The AI Wound Monitoring system will be integrated into MDCE's 2026 beta app launch as part of its broader digital health ecosystem.

Visit https://medicalcaretechnologies.com for more details.

Safe Harbor Statement:
This press release contains forward-looking statements within the meaning of federal securities laws. Actual results may differ materially due to risks and uncertainties, including market conditions, regulatory approvals, and product development timelines. Medical Care Technologies Inc. undertakes no obligation to update these statements except as required by law.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)



View the original press release on ACCESS Newswire

FAQ

What is MDCE's new AI Wound Monitoring System and how does it work?

MDCE's AI Wound Monitoring System uses smartphone imagery to provide real-time wound care diagnostics through sequential imaging algorithms, automated edge detection, and infection risk modeling to track healing and detect potential complications.

What is the market size for MDCE's wound care technology?

The chronic wound care market currently exceeds $20 billion annually and is projected to grow beyond $30 billion by 2030, driven by increasing rates of diabetes, obesity, and aging populations.

When will MDCE launch its AI Wound Monitoring System?

The AI Wound Monitoring System will be integrated into MDCE's beta app launch in 2026 as part of its digital health ecosystem.

How will MDCE's AI wound monitoring technology benefit healthcare?

The technology aims to reduce hospital readmissions, cut healthcare costs, and improve patient outcomes by providing a cost-effective alternative to expensive in-person wound assessments.

What are the target applications for MDCE's wound monitoring system?

The system targets chronic wound care management, particularly for patients with diabetes, obesity, and aging-related conditions, enabling remote monitoring by patients, caregivers, and clinicians.